Evidence map›Paper›PMID 34062937›Full record

Trial reportNutrients2021

Effect of Oat β-Glucan on Affective and Physical Feeling States in Healthy Adults: Evidence for Reduced Headache, Fatigue, Anxiety and Limb/Joint Pains.

Thomas M S Wolever, Maike Rahn, El Hadji Dioum, Alexandra L Jenkins, Adish Ezatagha, Janice E Campbell, YiFang Chu

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Multiple Antioxidative and Bioactive Molecules of Oats (Antioxidants (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Thomas M S WoleverFormerly GI Labs, INQUIS Clinical Research, Ltd., Toronto, ON M5C 2N8, Canada.
Maike RahnQuaker Oats Center of Excellence, PepsiCo R&D Nutrition, Barrington, IL 60010, USA.
El Hadji DioumQuaker Oats Center of Excellence, PepsiCo R&D Nutrition, Barrington, IL 60010, USA.ORCID 0000-0001-9486-1124
Alexandra L JenkinsFormerly GI Labs, INQUIS Clinical Research, Ltd., Toronto, ON M5C 2N8, Canada.
Adish EzataghaFormerly GI Labs, INQUIS Clinical Research, Ltd., Toronto, ON M5C 2N8, Canada.
Janice E CampbellFormerly GI Labs, INQUIS Clinical Research, Ltd., Toronto, ON M5C 2N8, Canada.
YiFang ChuQuaker Oats Center of Excellence, PepsiCo R&D Nutrition, Barrington, IL 60010, USA.

Funding

PepsiCo n/a
6 · The paper itself

Abstract

The gastrointestinal (GI) side-effects of dietary fibers are recognized, but less is known about their effects on non-GI symptoms. We assessed non-GI symptoms in a trial of the LDL-cholesterol lowering effect of oat β-glucan (OBG). Participants (

Indexed as

AdolescentAdultAffectAgedAnxietybeta-GlucansChi-Square DistributionCholesterol, LDLC-Reactive ProteinDietary FiberDouble-Blind MethodEatingFastingFatigueFemaleGastrointestinal Tractbeta-glucan, (1-3)(1-4)-beta-GlucansCholesterol, LDLC-Reactive ProteinDietary Fiberbeta-glucandietary fibergastrointestinal tracthumansmusculo-skeletal systemoatmealoatsrandomized clinical trialsymptoms

Identifiers

PMID34062937
PMCPMC8147290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.